174 related articles for article (PubMed ID: 37916482)
1. Cryoglobulinemic vasculitis: a 2023 update.
Moretti M; Ferro F; Baldini C; Mosca M; Talarico R
Curr Opin Rheumatol; 2024 Jan; 36(1):27-34. PubMed ID: 37916482
[TBL] [Abstract][Full Text] [Related]
2. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements.
Dammacco F; Lauletta G; Vacca A
Clin Exp Med; 2023 Jun; 23(2):255-272. PubMed ID: 35348938
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
4. Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC).
Quartuccio L; Bortoluzzi A; Scirè CA; Marangoni A; Del Frate G; Treppo E; Castelnovo L; Saccardo F; Zani R; Candela M; Fraticelli P; Mazzaro C; Renoldi P; Scaini P; Filippini DA; Visentini M; Scarpato S; Giuggioli D; Mascia MT; Sebastiani M; Zignego AL; Lauletta G; Fiorilli M; Casato M; Ferri C; Pietrogrande M; Pioltelli PE; De Vita S; Monti G; Galli M
Clin Rheumatol; 2023 Feb; 42(2):359-370. PubMed ID: 36169798
[TBL] [Abstract][Full Text] [Related]
5. Rapid improvement of psychiatric stigmata after IFN-free treatment in HCV patients with and without cryoglobulinemic vasculitis.
Gragnani L; Lorini S; Martini L; Stasi C; Visentini M; Petraccia L; Marello N; Monti M; Marri S; Madia F; Ricca V; Zignego AL
Clin Rheumatol; 2022 Jan; 41(1):147-157. PubMed ID: 34409558
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature.
Giuggioli D; Manfredi A; Colaci M; Manzini CU; Antonelli A; Ferri C
Autoimmun Rev; 2013 Sep; 12(11):1058-63. PubMed ID: 23806565
[TBL] [Abstract][Full Text] [Related]
7. The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents.
Roccatello D; Sciascia S; Rossi D; Solfietti L; Fenoglio R; Menegatti E; Baldovino S
Oncotarget; 2017 Jun; 8(25):41764-41777. PubMed ID: 28454112
[TBL] [Abstract][Full Text] [Related]
8. The dilemma of treating hepatitis C virus-associated cryoglobulinemia.
Roccatello D; Fenoglio R; Sciascia S
Curr Opin Rheumatol; 2019 Sep; 31(5):499-504. PubMed ID: 31090590
[TBL] [Abstract][Full Text] [Related]
9. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
[TBL] [Abstract][Full Text] [Related]
10. Impact of direct acting antivirals on hepatitis C virus-related cryoglobulinemic syndrome.
Zignego AL; Marri S; Gragnani L
Minerva Gastroenterol (Torino); 2021 Sep; 67(3):218-226. PubMed ID: 33793154
[TBL] [Abstract][Full Text] [Related]
11. New insights in cryoglobulinemic vasculitis.
Silva F; Pinto C; Barbosa A; Borges T; Dias C; Almeida J
J Autoimmun; 2019 Dec; 105():102313. PubMed ID: 31383568
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis C Virus-Induced Cryoglobulinemic Vasculitis].
Minami Y; Kudo M
Brain Nerve; 2018 Feb; 70(2):133-137. PubMed ID: 29433114
[TBL] [Abstract][Full Text] [Related]
13. Rheumatologic manifestations of Hepatitis C Virus.
Treppo E; Quartuccio L; Ragab G; DE Vita S
Minerva Med; 2021 Apr; 112(2):201-214. PubMed ID: 33263372
[TBL] [Abstract][Full Text] [Related]
14. Understanding the Cryoglobulinemias.
Fuentes A; Mardones C; Burgos PI
Curr Rheumatol Rep; 2019 Nov; 21(11):60. PubMed ID: 31741077
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus- related cryoglobulinemic vasculitis: A review of the role of the new direct antiviral agents (DAAs) therapy.
Mazzaro C; Dal Maso L; Mauro E; Visentini M; Tonizzo M; Gattei V; Andreone P; Pozzato G
Autoimmun Rev; 2020 Aug; 19(8):102589. PubMed ID: 32540448
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis.
Dammacco F; Lauletta G; Russi S; Leone P; Tucci M; Manno C; Monaco S; Ferrari S; Vacca A; Racanelli V
Clin Exp Med; 2019 Feb; 19(1):1-21. PubMed ID: 30430284
[TBL] [Abstract][Full Text] [Related]
17. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term cryoglobulinemic vasculitis outcomes after HCV eradication with direct-acting antivirals in the real-life.
Gragnani L; Lorini S; Marri S; Vacchi C; Madia F; Monti M; Ferri C; Zignego AL
Autoimmun Rev; 2022 Jan; 21(1):102923. PubMed ID: 34419670
[TBL] [Abstract][Full Text] [Related]
19. [Cryoglobulins and cryoglobulinemic vasculitis].
Suszek D; Majdan M
Wiad Lek; 2018; 71(1 pt 1):59-63. PubMed ID: 29558353
[TBL] [Abstract][Full Text] [Related]
20. Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.
Mathur P; Emmanuel B; Sneller M; Zhang X; Poonia B; Kottilil S
J Med Virol; 2018 May; 90(5):936-941. PubMed ID: 29236302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
